Syndax Pharmaceuticals (SNDX) PT Raised to $27 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Corinne Johnson raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $27.00 (from $26.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
